Table 3 Clinical characteristics of subtypes
From: Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
| Â | TCGA data | GEO data | |||||
|---|---|---|---|---|---|---|---|
EC1 | EC2–3 | P values | EC1 | EC2–3 | P values | ||
Age (mean ± SD) | 63.5 ± 10.9 | 60.2 ± 12.5 | 0.01168 | NA | NA | NA | |
Gender | male | 66 | 224 | 1 | 81 | 79 | 0.04636 |
female | 35 | 116 | 38 | 64 (3NA) | |||
Pathological grade | Grade 1 + 2 | 20 | 174 | 4.67e-08 | 43 | 69 | 0.05186 |
Grade 3 + 4 | 81 | 166 | 74(2NA) | 70 (7NA) | |||
Stage | Stage I–II | 35 | 220 | 1.478e-07 | 22 | 31 | 0.09323 |
Stage III-IV | 66 | 120 | 42 (55NA) | 30 (85NA) | |||